Exploring patient journeys through acne healthcare: a patient perspective

References

• Hay RJ, Johns NE, Williams HC, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134(6):1527–1534.
   PubMed Web of Science ®Google Scholar
• Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–2196.
   PubMed Web of Science ®Google Scholar
• Tan JK, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015;172:3–12.
   PubMed Web of Science ®Google Scholar
• Chernyshov P, Tomas‐Aragones L, Manolache L, et al. Quality of life measurement in atopic dermatitis. Position paper of the European Academy of Dermatology and Venereology (EADV) Task Force on Quality of Life. J Eur Acad Dermatol Venereol. 2017;31(4):576–593.
   PubMed Web of Science ®Google Scholar
• Hosthota A, Bondade S, Basavaraja V. Impact of acne vulgaris on quality of life and self-esteem. Cutis. 2016;98(2):121–124.
   PubMed Web of Science ®Google Scholar
• Cheng CE, Irwin B, Mauriello D, et al. Self‐reported acne severity, treatment, and belief patterns across multiple racial and ethnic groups in adolescent students. Pediatr Dermatol. 2010;27(5):446–452.
   PubMed Web of Science ®Google Scholar
• Smithard A, Glazebrook C, Williams H. Acne prevalence, knowledge about acne and psychological morbidity in mid‐adolescence: a community‐based study. Br J Dermatol. 2001;145(2):274–279.
   PubMed Web of Science ®Google Scholar
• Sanden K, Smit W, Dashorst M. The referencing document of the Dutch national qualification framework to the European qualification framework. Brussels: European Commission; 2012.
   Google Scholar
• Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945–973.e33.
   PubMed Web of Science ®Google Scholar
• Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60(5 Suppl.):S1–S50.
   PubMed Web of Science ®Google Scholar
• Nast A, Dreno B, Bettoli V, et al. European evidence‐based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26:1–29.
   PubMed Web of Science ®Google Scholar
• Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012;379(9813):361–372.
   PubMed Web of Science ®Google Scholar
• Barbaric J, Abbott R, Posadzki P, et al. Light therapies for acne: abridged Cochrane systematic review including GRADE assessments. Br J Dermatol. 2018;178(1):61–75.
   PubMed Web of Science ®Google Scholar
• De Vries F, Meulendijks A, Driessen R, et al. The efficacy and safety of non-pharmacological therapies for the treatment of acne vulgaris: a systematic review and best-evidence synthesis. J Eur Acad Dermatol Venereol. 2018;32(7):1195–1203.
   PubMed Web of Science ®Google Scholar
• Dréno B, Fischer T, Perosino E, et al. Expert opinion: efficacy of superficial chemical peels in active acne management—what can we learn from the literature today? Evidence-based recommendations. J Eur Acad Dermatol Venereol. 2011;25(6):695–704.
   PubMed Web of Science ®Google Scholar
• Haedersdal M, Togsverd-Bo K, Wulf HC. Evidence-based review of lasers, light sources and photodynamic therapy in the treatment of acne vulgaris. J Eur Acad Dermatol Venereol. 2008;22(3):267–278.
   PubMed Web of Science ®Google Scholar
• Šitum M, Franceschi D, Franceschi N. Challenges and strategies in dermatologic therapy – personalized medicine, patient safety and pharmacoeconomics. Dermatol Ther. 2019;32(4):e13011.
   PubMed Web of Science ®Google Scholar
• Tan J, Kang S, Leyden J. Prevalence and risk factors of acne scarring among patients consulting dermatologists in the USA. J Drugs Dermatol. 2017;16(2):97–102.
   PubMed Web of Science ®Google Scholar
• Trebble TM, Hansi N, Hydes T, et al. Process mapping the patient journey: an introduction. BMJ. 2010;341:c4078.
   PubMed Web of Science ®Google Scholar
• Bettoli V, Pasquinucci S, Caracciolo S, et al. The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities. J Eur Acad Dermatol Venereol. 2016;30(11):1965–1970.
   PubMed Web of Science ®Google Scholar
• Pereira da Veiga CR, Veiga C, Drummond-Lage AP, et al. Melanoma patient journey: understanding resource use and bridging the gap between dermatologist, surgeon and oncologist in different healthcare systems. SSRN Electron J. 2018.
   Google Scholar
• Kuo S, Huang KE, Davis SA, et al. The rosacea patient journey: a novel approach to conceptualizing patient experiences. Cutis. 2015;95(1):37–43.
   PubMed Web of Science ®Google Scholar
• Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–349.
   PubMed Web of Science ®Google Scholar
• LimeSurvey GH. Survey software; [cited Apr 2020]. Available from: http://limesurvey.org
   Google Scholar
• Thiboutot DM, Dréno B, Abanmi A, et al. Practical management of acne for clinicians: an international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2018;78(2 Suppl. 1):S1–S23.e1.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Acne vulgaris: establishing effectiveness of drugs intended for treatment guidance for industry; 2018. Available from: https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm
   Google Scholar
• Wei EX, Kirsner RS, Eaglstein WH. End points in dermatologic clinical trials: a review for clinicians. J Am Acad Dermatol. 2016;75(1):203–209.
   PubMed Web of Science ®Google Scholar
• Verhoeven EW, Kraaimaat FW, van Weel C, et al. Skin diseases in family medicine: prevalence and health care use. Ann Fam Med. 2008;6(4):349–354.
   PubMed Web of Science ®Google Scholar
• Lowell BA, Froelich CW, Federman DG, et al. Dermatology in primary care: prevalence and patient disposition. J Am Acad Dermatol. 2001;45(2):250–255.
   PubMed Web of Science ®Google Scholar
• Desai KP, Martyn-Simmons C, Viner R, et al. Help-seeking behaviours, opportunistic treatment and psychological implications of adolescent acne: cross-sectional studies in schools and hospital outpatient departments in the UK. BMJ Open. 2017;7(9):e016964.
   PubMed Web of Science ®Google Scholar
• Corey KC, Cheng CE, Irwin B, et al. Self‐reported help‐seeking behaviors and treatment choices of adolescents regarding acne. Pediatr Dermatol. 2013;30(1):36–41.
   PubMed Web of Science ®Google Scholar
• Koopmans GT, Lamers LM. Gender and health care utilization: the role of mental distress and help-seeking propensity. Soc Sci Med. 2007;64(6):1216–1230.
   PubMed Web of Science ®Google Scholar
• Nijsten T, Rombouts S, Lambert J. Acne is prevalent but use of its treatments is infrequent among adolescents from the general population. J Eur Acad Dermatol Venerol. 2007;21(2):163–168.
   PubMed Web of Science ®Google Scholar
• Davis SA, Himmler S, Feldman SR. Cost-effectiveness analysis of using dermatologists versus pediatricians to treat mild to moderate acne. Dermatol Online J. 2017;23(5).
   Google Scholar
• Skroza N, Tolino E, Mambrin A, et al. Adult acne versus adolescent acne: a retrospective study of 1,167 patients. J Clin Aesthet Dermatol. 2018;11(1):21–25.
   PubMedGoogle Scholar